90 related articles for article (PubMed ID: 8876041)
1. JMV641: a potent bombesin receptor antagonist that inhibits Swiss 3T3 cell proliferation.
Azay J; Gagne D; Devin C; Llinares M; Fehrentz JA; Martinez J
Regul Pept; 1996 Aug; 65(1):91-7. PubMed ID: 8876041
[TBL] [Abstract][Full Text] [Related]
2. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of in vitro and in vivo activities of bombesin pseudopeptide analogs modified on the C-terminal dipeptide fragment.
Azay J; Nagain C; Llinares M; Devin C; Fehrentz JA; Bernad N; Roze C; Martinez J
Peptides; 1998; 19(1):57-63. PubMed ID: 9437737
[TBL] [Abstract][Full Text] [Related]
4. A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor.
Oiry C; Pannequin J; Bernad N; Artis AM; Galleyrand JC; Devin C; Cristau M; Fehrentz JA; Martinez J
Eur J Pharmacol; 2000 Sep; 403(1-2):17-25. PubMed ID: 10969139
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of bombesin constrained analogues.
Cristau M; Devin C; Oiry C; Chaloin O; Amblard M; Bernad N; Heitz A; Fehrentz JA; Martinez J
J Med Chem; 2000 Jun; 43(12):2356-61. PubMed ID: 10882361
[TBL] [Abstract][Full Text] [Related]
6. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue.
Camble R; Cotton R; Dutta AS; Garner A; Hayward CF; Moore VE; Scholes PB
Life Sci; 1989; 45(17):1521-7. PubMed ID: 2555638
[TBL] [Abstract][Full Text] [Related]
7. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
[TBL] [Abstract][Full Text] [Related]
8. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
Cai RZ; Reile H; Armatis P; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
[TBL] [Abstract][Full Text] [Related]
9. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
[TBL] [Abstract][Full Text] [Related]
10. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
Benya RV; Fathi Z; Kusui T; Pradhan T; Battey JF; Jensen RT
Mol Pharmacol; 1994 Aug; 46(2):235-45. PubMed ID: 8078487
[TBL] [Abstract][Full Text] [Related]
11. Antagonists of bombesin/gastrin releasing peptide based on [D-Ala24]GRP(20-26)-heptapeptide. Modifications leading to potent analogues with prolonged duration of action.
Best JR; Cotton R; Dutta AS; Fleming B; Garner A; Gormley JJ; Hayward CF; McLachlan PF; Scholes PB
Drug Des Deliv; 1990 Oct; 6(4):255-71. PubMed ID: 1707276
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of C-terminal hydroxamide analogues of bombesin.
Devin C; Bernad N; Cristau M; Artis-Noel AM; Heitz A; Fehrentz JA; Martinez J
J Pept Sci; 1999 Apr; 5(4):176-84. PubMed ID: 10323197
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for selectivity of high affinity peptide antagonists for the gastrin-releasing peptide receptor.
Tokita K; Katsuno T; Hocart SJ; Coy DH; Llinares M; Martinez J; Jensen RT
J Biol Chem; 2001 Sep; 276(39):36652-63. PubMed ID: 11463790
[TBL] [Abstract][Full Text] [Related]
14. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and biological activities of potent bombesin receptor antagonists.
Llinares M; Devin C; Chaloin O; Azay J; Noel-Artis AM; Bernad N; Fehrentz JA; Martinez J
J Pept Res; 1999 Mar; 53(3):275-83. PubMed ID: 10231715
[TBL] [Abstract][Full Text] [Related]
16. Homodimeric forms of bombesin act as potent antagonists of bombesin on Swiss 3T3 cells.
Gawlak SL; Kiener PA; Braslawsky GR; Greenfield RS
Growth Factors; 1991; 5(2):159-70. PubMed ID: 1662974
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of bombesin-stimulated phospholipase C beta and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P.
Mitchell FM; Heasley LE; Qian NX; Zamarripa J; Johnson GL
J Biol Chem; 1995 Apr; 270(15):8623-8. PubMed ID: 7536738
[TBL] [Abstract][Full Text] [Related]
18. [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells.
Woll PJ; Coy DH; Rozengurt E
Biochem Biophys Res Commun; 1988 Aug; 155(1):359-65. PubMed ID: 2843183
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the effects of bombesin antagonists on cell proliferation and intracellular calcium concentration in Swiss 3T3 and HT-29 cell lines.
Casanueva FF; Perez FR; Casabiell X; Camiña JP; Cai RZ; Schally AV
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1406-11. PubMed ID: 8643644
[TBL] [Abstract][Full Text] [Related]
20. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi.
Cai RZ; Radulovic S; Pinski J; Nagy A; Redding TW; Olsen DB; Schally AV
Peptides; 1992; 13(2):267-71. PubMed ID: 1409006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
